48.31
price up icon0.58%   0.28
after-market Dopo l'orario di chiusura: 48.31
loading

Akero Therapeutics Inc Azioni (AKRO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
5.14%
50.65
53.39 38.63 27.98 21.79
Interest Income/Expense
10.48%
0.991
0.897 0.888 0.857 0.457
Operating Income/Loss
3.10%
-59.95
-61.87 -46.62 -35.63 -28.75
Income/Loss From Continuing Operations Before Tax
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Income/Loss From Continuing Operations After Tax
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Net Income/Loss
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,488%
59.31
1.0614 55.61 51.87 46.94
Diluted Average Shares
5,488%
59.31
1.0614 55.61 51.87 46.94
Basic Earnings Per Share
11.76%
-0.90
-1.02 -0.71 -0.60 -0.55
Diluted Earnings Per Share
11.76%
-0.90
-1.02 -0.71 -0.60 -0.55
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Capitalizzazione:     |  Volume (24 ore):